Literature DB >> 17530265

[Growth factors].

N Hunzelmann1, S Eming, S Rosenkranz.   

Abstract

Growth factors such as PDGF, VEGF and TGF-beta play a pivotal role in the regulation and differentiation of different cell types in the connective tissue, for example fibroblasts and endothelial cells, and in the immune system. Pathophysiologically, these growth factors are thought to play a central role in tumorigenesis, and the use of their inhibitors has led to substantial improvements in tumor therapy. Recent findings also support an important role for growth factors in inflammatory rheumatoid diseases. New developments in the understanding and potential role of these factors in the pathophysiology of rheumatic diseases will be discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17530265     DOI: 10.1007/s00393-007-0175-3

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  28 in total

Review 1.  The PDGF family: four gene products form five dimeric isoforms.

Authors:  Linda Fredriksson; Hong Li; Ulf Eriksson
Journal:  Cytokine Growth Factor Rev       Date:  2004-08       Impact factor: 7.638

2.  Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis.

Authors:  Silvia Svegliati Baroni; Mariarosaria Santillo; Federica Bevilacqua; Michele Luchetti; Tatiana Spadoni; Matteo Mancini; Paolo Fraticelli; Paola Sambo; Ada Funaro; Andrius Kazlauskas; Enrico V Avvedimento; Armando Gabrielli
Journal:  N Engl J Med       Date:  2006-06-22       Impact factor: 91.245

3.  Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.

Authors:  Karri Paavonen; Jami Mandelin; Taina Partanen; Lotta Jussila; Tian-Fang Li; Ari Ristimaki; Kari Alitalo; Yrjö T Konttinen
Journal:  J Rheumatol       Date:  2002-01       Impact factor: 4.666

4.  Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.

Authors:  Jörg H W Distler; Astrid Jüngel; Lars C Huber; Ursula Schulze-Horsel; Jochen Zwerina; Renate E Gay; Beat A Michel; Thomas Hauser; Georg Schett; Steffen Gay; Oliver Distler
Journal:  Arthritis Rheum       Date:  2007-01

5.  Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors.

Authors:  H Ihn; K Yamane; M Kubo; K Tamaki
Journal:  Arthritis Rheum       Date:  2001-02

6.  Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/macrophages.

Authors:  Masato Murakami; Shinobu Iwai; Sachie Hiratsuka; Mai Yamauchi; Kazuhide Nakamura; Yoichiro Iwakura; Masabumi Shibuya
Journal:  Blood       Date:  2006-05-18       Impact factor: 22.113

7.  Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis.

Authors:  Michel De Bandt; Meriem H Ben Mahdi; Véronique Ollivier; Maggy Grossin; Magali Dupuis; Murielle Gaudry; Peter Bohlen; Kenneth E Lipson; Audie Rice; Yan Wu; Marie-Anne Gougerot-Pocidalo; Catherine Pasquier
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

8.  Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney.

Authors:  Y Isaka; D K Brees; K Ikegaya; Y Kaneda; E Imai; N A Noble; W A Border
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

Review 9.  Vascular endothelial growth factor: basic science and clinical progress.

Authors:  Napoleone Ferrara
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

Review 10.  Vascular endothelial growth factor (VEGF) in autoimmune diseases.

Authors:  Jozélio Freire Carvalho; Miri Blank; Yehuda Shoenfeld
Journal:  J Clin Immunol       Date:  2007-03-06       Impact factor: 8.542

View more
  2 in total

1.  Expression of vascular endothelial growth factor receptor 2 (VEGFR-2), inducible nitric oxide synthase (iNOS), and Ki-M1P in skull base chordoma: a series of 145 tumors.

Authors:  R Akhavan-Sigari; M R Gaab; V Rohde; A Brandis; H Tezval; M Abili; K von Eckardstein; H Ostertag
Journal:  Neurosurg Rev       Date:  2013-09-03       Impact factor: 3.042

Review 2.  IGFs in Dentin Formation and Regeneration: Progress and Remaining Challenges.

Authors:  Pengcheng He; Liwei Zheng; Xin Zhou
Journal:  Stem Cells Int       Date:  2022-04-06       Impact factor: 5.443

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.